CD34 (+) cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory angina

Patients with refractory angina who are suboptimal candidates for further revascularization have improved exercise time, decreased angina frequency, and reduced major adverse cardiac events with intramyocardial delivery of CD34(+) cells. However, the effect of CD34(+) cell therapy on health care exp...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Stem Cells Transl Med
Prif Awduron: Johnson, Grace L., Henry, Timothy D., Povsic, Thomas J., Losordo, Douglas W., Garberich, Ross F., Stanberry, Larissa I., Strauss, Craig E., Traverse, Jay H.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley & Sons, Inc. 2020
Pynciau:
Human Clinical Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7519768/
https://ncbi.nlm.nih.gov/pubmed/32531108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.20-0046
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg